Relationships between concentrations of cerebrospinal fluid (CSF) kynurenic acid (KYNA) and suicidal behavior were evaluated in 59 patients with psychosis after 22 years of follow-up . Three patients died from suicide and nine patients had a history of attempted suicide. Patients with attempted suicide had significantly lower concentrations of CSF KYNA.
Introduction
Schizophrenia is a devastating disorder with a high suicide risk (Carlborg et al., 2010) . Brain dopamine hyperactivity has been the predominating hypothesis of schizophrenia but in recent years also other hypotheses including aberrations in glutamatergic signaling has received considerable attention. Thus compounds blocking the glutamatergic N-methyl-D-aspartate (NMDA) receptor, e.g. phencyclidine (PCP), induce both positive and negative symptoms as well as cognitive deficits in healthy humans and aggravates psychotic symptoms in patients with schizophrenia (Jentsch and Roth, 1999) .
Kynurenic acid (KYNA), an endogenous tryptophan metabolite, antagonizes both the NMDA receptor (Kessler et al., 1989) and the cholinergic alpha7 n nicotinic receptor (Hilmas et al., 2001) in the brain. Elevated concentrations of KYNA have been found in the cerebrospinal fluid (CSF) (Nilsson et al., 2005) and in the postmortem prefrontal cortex (Sathyasaikumar et al., 2011) of patients with schizophrenia. Interestingly, CSF KYNA has been correlated positively with CSF 5-hydroxyindoleacetic acid (5-HIAA) (Nilsson et al., 2007) , the major metabolite of serotonin, which has been associated with suicidal behavior among patients with major depression (Åsberg, 1997) . A recent study analyzed 20 CSF biomarkers among suicide attempters without finding KYNA to load on any specific factor in a principal component analysis (Lindqvist et al., 2011) . In another report plasma concentration of kynurenin, the immediate precursor of KYNA was higher among suicide attempters with major depressive disorder than nonattempters (Sublette et al., 2011) .
The objective of the present study was to investigate the relationships between CSF KYNA concentrations and suicidal behavior in a long-term cohort of patients with schizophrenia spectrum psychosis. We also investigated whether CSF KYNA concentrations were correlated with severity of disease as measured by the proportion of days admitted to a psychiatric inpatient clinic during time of follow-up .
Methods
The Regional Ethical Review Board in Stockholm approved the study (2006/ 408-31/4) . The samples consisted in part of patients from a cohort earlier described (Carlborg et al., 2009 ).
The present sample consisted of 59 patients (35 men, 24 women) admitted and hospitalized between the year 1979 and 1987 at onset of illness with symptoms of psychosis, i.e. hallucinations, delusions or disorganized behavior and from whom CSF was collected. Age (mean 7standard deviation (S.D.)) at index admission was 31.2 7 8.1 years, range 18.1-51.4 years without any significant difference between men (30.5 77.7 years) and women (32.2 7 8.7 years). Mean follow-up time was 22.1 75.5 years (men 22.3 7 5.2 vs. women 22.07 6.1 years).
CSF was obtained by lumbar puncture in a standardized manner (Sedvall and Wode-Helgodt, 1980) . The determination of CSF KYNA concentrations was performed using an isocratic reversed-phase high performance liquid chromatography (HPLC), as previously described (Nilsson et al., 2005) .
CSF samples were coded, stored and blindly analyzed with regard to KYNA concentrations.
Information about discharge diagnosis, length and frequency of hospital admissions were retrieved from the Swedish Inpatient Register. A lifetime main clinical diagnosis based on International Classification of Diseases (ICD 8-10 ) was given to each patient according to a hierarchy earlier described (Vares et al., 2006 Register at the National Board of Health and Welfare. Time of follow-up ended in July 2006 or at time for death. The available medical records were scrutinized for information about previous suicide attempts.
In initial analyses evaluating skewness and kurtosis with Shapiro-Wilks test, CSF KYNA concentrations were not normally distributed and therefore transformed into normal distribution using the natural logarithms. As CSF KYNA concentrations correlated with age (r¼ 0.30, P¼0.02), all group comparisons of CSF KYNA values were adjusted for age using linear regression. Po0.05 was considered significant. JMP 7, SAS Institute inc., was used for all statistical analyses.
Results
The patients received a main lifetime diagnosis of schizophrenia (n¼31), psychosis not otherwise specified (n¼14), schizoaffective disorder (n¼4), schizophreniform disorder (n¼3) and delusional disorder (n¼ 1). Six patients received a lifetime main diagnosis outside the non-organic psychotic spectrum. None of the patients had a diagnosis of co-morbid mood disorder or substance abuse. Mean number of days admitted to a psychiatric inpatient clinic was 44.2764.3 day/year for the patients, similar in men (44.6756.3) and women (43.7775.7 years). Four patients were drug-naïve, 29 were drug free and 26 were on neuroleptic medication at time of lumbar puncture. There was no significant difference in mean CSF KYNA concentrations between these groups (1.8271.36, 1.3470.78, and 1.6271.41 nM, respectively).
Of the 59 patients three (5%), one man and two women died from suicide during the follow-up by jumping from high places or drowning. Time from lumbar puncture to suicide was 8.478.2 years, range 3.4-17.9 years. Medical records for 39 of the patients were possible to retrieve. From analysis of these records nine patients (23%) had a history of attempted suicide at initial admission or during follow-up . Fig. 1 shows CSF KYNA concentrations in suicide attempters and non-attempters adjusted for age. Mean CSF KYNA concentrations were significantly lower in suicide attempters compared to patients lacking history of suicide attempt (0.83 70.49 and 1.6871.42 nM, respectively; F¼7.5, P ¼0.009). CSF KYNA concentrations were positively correlated with CSF 5-HIAA concentrations (r¼ 0.64, Po0.001).
The correlation between CSF KYNA concentrations and number of days hospitalized was not significant (p¼0.8). No significant difference in mean CSF KYNA concentrations was found between the diagnostic groups or gender (men 1.3270.71, women 1.7671.4; p¼0.3).
Discussion
In the present study psychosis patients with a history of attempted suicide had significantly lower CSF KYNA concentrations at the onset of illness. CSF KYNA has been shown to correlate with CSF 5-HIAA (Nilsson et al., 2007) and this was also the case in our study. The reason for this correlation is unknown but might be related to the availability of tryptophan, the common precursor of both serotonin and KYNA (Nilsson et al., 2007) . Low concentrations of CSF 5-HIAA, a sign of dysfunction of the serotonin system, have been associated with suicidal behavior in mood disorders (Åsberg, 1997) and a combination of CSF biomarkers has been suggested as indicators of future suicidal behavior (Lindqvist et al., 2011) . However, a large study was unable to find an association between low concentrations of CSF 5-HIAA and suicidal behavior in patients with schizophrenia (Carlborg et al., 2009) .
Proportion of days admitted to a psychiatric inpatient clinic was used to correlate CSF KYNA concentrations with the severity of disease. No such correlation was found, suggesting that this proxy for disease severity is not influenced by CSF KYNA concentrations.
The present study is limited by the small sample size. Furthermore, we were not able to retrieve the medical records for all patients. Thus, information about prior suicide attempt may be lacking. The use of number of days admitted to an inpatient clinic may not fully account for the complexity of disease severity.
In conclusion, mean concentration of CSF KYNA at onset of illness was significantly lower in schizophrenia spectrum psychosis patients with a history of attempted suicide later in life. The neurochemical correlates of suicidal behavior need further investigation. 
